MARIETTA, Ga., Dec. 17, 2024 /PRNewswire/ — BRIJ Medical, Inc. has been awarded a breakthrough technology national group purchasing agreement in the “non-invasive skin closure” category with Premier, Inc. Effective December 15, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Brijjit® BP-100 and BP-75 Force Modulating Tissues Bridges. Premier offers Breakthrough Technology designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes and operational efficiencies.
“Being awarded a national group purchasing agreement with Premier is a transformative milestone for BRIJ Medical,” said Tim Gleeson, CEO. “This marks a significant step forward in our mission to improve the lives of both patients and surgeons post-surgery. Our product suite is designed to support both our surgeons and patients. As a team, we couldn’t be more excited about the opportunity to collaborate with Premier’s membership.”
The Brijjit Force Modulating Tissue Bridge offers a non-invasive solution for relieving up to 100% of incisional tension post-operatively. It is quick to apply, easy to remove and non-invasive — sitting on the skin, not in the skin.
Premier is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.
ABOUT SUPPLIER
BRIJ Medical is redefining incision management through active tension offloading and advanced incision protection. With a portfolio of innovative solutions that covers, protects, and reinforces incisions, BRIJ empowers surgeons from closure through recovery.
BRIJ-SEAL is an advanced wound closure device that provides a 14-day bacterial barrier, while Brijjit® is an active tension offloading device clinically shown to eliminate up to 100% of incisional tension.
Trusted by plastic and orthopedic surgeons across the U.S. and Canada, BRIJ Medical brings greater control and confidence to every stage of healing.



Share:
A Surge in Breast Reductions
BRIJ Medical Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort